During the past decade, Tel-Aviv Sourasky Medicak center / BMT Unit conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tel-Aviv Sourasky Medicak center / BMT Unit" #1 collaborator was "Novartis" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Tel-Aviv Sourasky Medicak center / BMT Unit" are "B Cell Lymphoma" (2 trials), "CART Treatment" (1 trials), "Febrile Neutropenia" (1 trials) and "Fever" (1 trials). Many other conditions were trialed in "Tel-Aviv Sourasky Medicak center / BMT Unit" in a lesser frequency.

Most popular intervention types in "Tel-Aviv Sourasky Medicak center / BMT Unit" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Ceftazidim" (1 trials), "Eltrombopag" (1 trials), "Meropenem" (1 trials), "Nivolumab Injection [Opdivo]" (1 trials) and "Piperacillin/tazobactam" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tel-Aviv Sourasky Medicak center / BMT Unit" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Tel-Aviv Sourasky Medicak center / BMT Unit". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Tel-Aviv Sourasky Medicak center / BMT Unit, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tel-Aviv Sourasky Medicak center / BMT Unit, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".